
John Berk
Airway Clinic Director · Boston Univ Sch of Med
Credentials: · · · ·
History
Research
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
New England Journal of Medicine · 2018 · 2,387 citations
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Circulation · 2016 · 1,659 citations
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
New England Journal of Medicine · 2018 · 1,143 citations

42 papers
- DS
30 papers

28 papers
- MS
25 papers

19 papers

18 papers
- MP
16 papers

16 papers
Grants
- 2005–2013
Effect of Diflunisal (IND68092) on Familial Amyloidosis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $5.6M · Boston University Medical Campus
- 2004–2009
Effect of Diflunisal on Familial Amyloidosis
Food and Drug Administration · R01
Contact PI · $632.2K · Boston University Medical Campus
- 1998–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $67.6K · Boston University Medical Campus
- 1996–2000
Retinoids and Collagen Transcription in Lung Fibroblasts
National Heart, Lung, and Blood Institute · K08
Contact PI · $371.1K · Boston University Medical Campus
Clinical trials
- 2018–2019
Principal investigator · Completed · Early phase 1
Boston University
- 2012–2015
Safety and Effect of Doxycycline in Patients With Amyloidosis
Principal investigator · Completed · Phase 2
Boston University
- 2006–2012
The Effect of Diflunisal on Familial Amyloidosis
Principal investigator · Completed · Phase 2, Phase 3
Boston University




